BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16258457)

  • 41. A Review of Barriers to Minorities' Participation in Cancer Clinical Trials: Implications for Future Cancer Research.
    Salman A; Nguyen C; Lee YH; Cooksey-James T
    J Immigr Minor Health; 2016 Apr; 18(2):447-53. PubMed ID: 25822567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccine. Researchers lament low minority participation in trials.
    AIDS Policy Law; 2006 Feb; 21(3):5. PubMed ID: 16509015
    [No Abstract]   [Full Text] [Related]  

  • 43. Enhancing recruitment and retention of minority young women in community-based clinical research.
    Wiemann CM; Chacko MR; Tucker JC; Velasquez MM; Smith PB; DiClemente RJ; von Sternberg K
    J Pediatr Adolesc Gynecol; 2005 Dec; 18(6):403-7. PubMed ID: 16338606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strategies to enhance patient recruitment and retention in research involving patients with a first episode of mental illness.
    Furimsky I; Cheung AH; Dewa CS; Zipursky RB
    Contemp Clin Trials; 2008 Nov; 29(6):862-6. PubMed ID: 18721902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strengthening accrual to cancer clinical trials.
    Trimble EL; Denicoff AM; Abrams JS
    Gynecol Oncol; 2010 Mar; 116(3):291-2. PubMed ID: 20152512
    [No Abstract]   [Full Text] [Related]  

  • 46. A research nurse: enhancing participation in clinical trials.
    O'Halloran LJ; Curl VR; Hagen L; Sveningson L
    Prog Clin Biol Res; 1989; 293():355-60. PubMed ID: 2726947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical trials in a rural population: professional education aspects.
    Maurer LH; Davis T; Hammond S; Smith E; West P; Doolittle M
    J Cancer Educ; 2001; 16(2):89-92. PubMed ID: 11440069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The challenge of early breast cancer detection among immigrant and minority women in multicultural societies.
    Remennick L
    Breast J; 2006; 12 Suppl 1():S103-10. PubMed ID: 16430393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with enrollment in cancer genetics research.
    Ford BM; Evans JS; Stoffel EM; BalmaƱa J; Regan MM; Syngal S
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1355-9. PubMed ID: 16835336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participant recruitment to a randomized trial of a community-based behavioral intervention for pre- and interconceptional women findings from the Central Pennsylvania Women's Health Study.
    Velott DL; Baker SA; Hillemeier MM; Weisman CS
    Womens Health Issues; 2008; 18(3):217-24. PubMed ID: 18457756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies and stakeholders: minority recruitment in cancer genetics research.
    James RD; Yu JH; Henrikson NB; Bowen DJ; Fullerton SM;
    Community Genet; 2008; 11(4):241-9. PubMed ID: 18417972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bringing cures to all patients: addressing diversity in clinical trials.
    Biedrzycki BA
    ONS Connect; 2007; 22(8 Suppl):5-6. PubMed ID: 17824541
    [No Abstract]   [Full Text] [Related]  

  • 54. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
    Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
    Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer adolescent pathway in France between 1988 and 1997.
    Desandes E; Lacour B; Sommelet D; White-Koning M; Velten M; Tretarre B; Marr A; Maarouf N; Guizard AV; Delafosse P; Danzon A; Cotte C; Brugieres L
    Eur J Oncol Nurs; 2007 Feb; 11(1):74-81. PubMed ID: 16814605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials.
    Lai GY; Gary TL; Tilburt J; Bolen S; Baffi C; Wilson RF; Howerton MW; Gibbons MC; Tanpitukpongse TP; Powe NR; Bass EB; Ford JG
    Clin Trials; 2006; 3(2):133-41. PubMed ID: 16773955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recruiting minorities into clinical trials: toward a participant-friendly system.
    Swanson GM; Ward AJ
    J Natl Cancer Inst; 1995 Dec; 87(23):1747-59. PubMed ID: 7473831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual.
    Ghebre RG; Jones LA; Wenzel JA; Martin MY; Durant RW; Ford JG
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1122-30. PubMed ID: 24643650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cooperative clinical trials and community outreach: the conceptual approach in Northern California.
    Carter SK
    Cancer Clin Trials; 1978; 1(4):307-13. PubMed ID: 757148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials.
    Niranjan SJ; Durant RW; Wenzel JA; Cook ED; Fouad MN; Vickers SM; Konety BR; Rutland SB; Simoni ZR; Martin MY
    J Cancer Educ; 2019 Feb; 34(1):26-34. PubMed ID: 28776305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.